We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > autoimmune disorders

News List

EVOQ Announces License, Collaboration Agreement with Amgen americanpharmaceuticalreview
January 21, 2021
EVOQ Therapeutics announced a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders.
EVOQ Therapeutics and Amgen Partner contractpharma
January 14, 2021
EVOQ Therapeutics has signed a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders.
Sanofi to acquire Synthorx for $2.5 B biospectrumasia
December 12, 2019
Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.